<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Vascular dysfunction, low-grade <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and impaired fibrinolysis have each been reported to be present in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but their relationships, and the role of <z:hpo ids='HP_0001513'>obesity</z:hpo>, have not been investigated </plain></SENT>
<SENT sid="1" pm="."><plain>We measured insulin sensitivity (euglycemic clamp), forearm blood flow responses to graded local <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> (<z:chebi fb="93" ids="22614">Ach</z:chebi>) and <z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi> (SNP) infusions, plasma concentrations of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-alpha, interleukin (IL)-6, <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (vWF), plasminogen activator inhibitor (PAI)-1, tissue plasminogen activator (tPA), and high-sensitivity C-reactive protein (hs-CRP) in 81 diabetic patients </plain></SENT>
<SENT sid="2" pm="."><plain>When patients were stratified by <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, more severe <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> was associated (P &lt; 0.05) with overweight, central fat distribution, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> (with similar sex distribution, age, fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, and HbA1c) </plain></SENT>
<SENT sid="3" pm="."><plain>With regard to vascular function, both endothelium-dependent (<z:chebi fb="93" ids="22614">Ach</z:chebi>) (-22, -40, and -52%; P &lt; 0.0001) and -independent (SNP) (-3, -7, and -27%; P &lt; 0.02) vasodilatation were progressively reduced across <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> tertiles </plain></SENT>
<SENT sid="4" pm="."><plain>In multivariate analysis, inflammatory markers (IL-6, hs-CRP, and TNF-alpha) were independently associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and fasting glycemia, fibrinolytic markers PAI-1 and tPA with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and central fat distribution, and vascular indexes (vWF, <z:chebi fb="93" ids="22614">Ach</z:chebi>, and SNP vasodilation) with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo> or cytokines (TNF-alpha or IL-6) </plain></SENT>
<SENT sid="5" pm="."><plain>In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is associated with vascular dysfunction/damage, impaired fibrinolysis, and low-grade <z:mp ids='MP_0001845'>inflammation</z:mp> independently of <z:hpo ids='HP_0001513'>obesity</z:hpo> and poor glycemic control </plain></SENT>
</text></document>